J Appl Biomed 16:66-74, 2018 | DOI: 10.1016/j.jab.2017.10.008
DNA repair inhibitors as radiosensitizers in human lung cells
- a University of Defence in Brno, Faculty of Military Health Sciences in Hradec Králové, Department of Radiobiology, Hradec Králové, Czech Republic
- b University of Defence in Brno, Faculty of Military Health Sciences in Hradec Králové, Department of Toxicology and Military Pharmacy, Hradec Králové, Czech Republic
- c University Hospital Hradec Králové, Biomedical Research Centre, Hradec Králové, Czech Republic
The aim of this study was to compare the effects of DNA repair inhibitors in the context of radio-sensitization of human lung cells. The radio-sensitizing effects of NU7441 (1 mM), an inhibitor of DNA-dependent protein kinase (DNA-PK); KU55933 (10 μM), an inhibitor of ataxia-telangiectasia mutated kinase (ATM); and VE-821 (10 μM), an inhibitor of ATM-related kinase (ATR) were tested by the xCELLigence system for monitoring proliferation, fluorescence microscopy for DNA damage detection, flow-cytometry for cell cycle and apoptosis analysis and western blotting and ELISA for determination of DNA repair proteins. We employed normal human lung fibroblasts (NHLF, p53-wild-type) and non-small cell lung cancer cells (H1299, p53-negative). DNA-PK inhibition (by NU7441) in combination with ionizing radiation (IR) increased the number of double strand breaks (DSB), which persisted 72 h after irradiation in both cell lines. Additionally, NU7441 and KU55933 in combination with IR caused G2-arrest. ATR inhibitor (VE-821) together with IR markedly inhibited proliferation and induced G2/M arrest accompanied by apoptosis in H1299, but not in NHLF cells, and thus diminished DNA-repair of tumour cells but not normal lung fibroblasts. Our findings indicate that ATR inhibition could be a promising therapeutic strategy in p53-deficient lung tumours.
Keywords: DNA repair; DNA-PK; ATM; ATR; Inhibition; Ionizing radiation; Lung cancer
Received: December 12, 2016; Revised: May 23, 2017; Accepted: October 24, 2017; Published: February 1, 2018 Show citation
References
- Ćmielová, J., Havelek, R., Vávrová, J., Řezáčová, M., 2015. Changes in the response of MCF-7 cells to ionizing radiation after the combination of ATM and DNA-PK inhibition. Med. Oncol. 32, 138.
Go to original source...
Go to PubMed...
- Allen, C., Halbrook, J., Nickoloff, J.A., 2003. Interactive competition between homologous recombination and non-homologous end joining. Mol. Cancer Res. 1, 913-920.
- An, B., Goldfarb, R.H., Siman, R., Dou, Q.P., 1998. Novel dipeptidyl proteasome inhibitors overcome Bcl-2 protective function and selectively accumulate the cyclin-dependent kinase inhibitor p27 and induce apoptosis in transformed but not normal, human fibroblasts. Cell Death Differ. 5, 1062-1075.
Go to original source...
Go to PubMed...
- Andrs, M., Korabecny, J., Jun, D., Hodny, Z., Bartek, J., Kuca, K., 2015. Phosphatidylinositol 3-Kinase (PI3K) and phosphatidylinositol 3-kinase-related kinase (PIKK) inhibitors: importance of the morpholine ring. J. Med. Chem. 58, 41-71.
Go to original source...
Go to PubMed...
- Baumann, P., West, S.C., 1998. DNA end-joining catalyzed by human cell-free extracts. PNAS 95, 14066-14070.
Go to original source...
Go to PubMed...
- Chaturvedi, P., Eng, W.K., Zhu, Y., Mattern, M.R., Mishra, R., Hurle, M.R., et al., 1999. Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway. Oncogene 18, 4047-4054.
Go to original source...
Go to PubMed...
- Christodoulou, M., Bayman, N., McCloskey, P., Rowbottom, C., Faivre-Finn, C., 2014. New radiotherapy approaches in locally advanced non-small cell lung cancer. Eur. J. Cancer 50, 525-534.
Go to original source...
Go to PubMed...
- Ciszewski, W.M., Tavecchio, M., Dastych, J., Curtin, N.J., 2014. DNA-PK inhibition by NU7441 sensitizes breast cancer cells to ionizing radiation and doxorubicin. Breast Cancer Res. Treat. 143, 47-55.
Go to original source...
Go to PubMed...
- Fuks, Z., Persaud, R.S., Alfieri, A., McLoughlin, M., Ehleiter, D., Schwartz, J.L., et al., 1994. Basic fibroblast growth factor protects endothelial cells against radiation-induced programmed cell death in vitro and in vivo. Cancer Res. 54, 2582-2590.
- Gérard, C., Debruyne, C., 2009. Immunotherapy in the landscape of new targeted treatments for non-small cell lung cancer. Mol. Oncol. 3, 409-424.
Go to original source...
Go to PubMed...
- Gatei, M., Sloper, K., Sorensen, C., Syljuäsen, R., Falck, J., Hobson, K., et al., 2003. Ataxia-telangiectasia-mutated (ATM) and NBS1-dependent phosphorylation of Chk1 on Ser-317 in response to ionizing radiation. J. Biol. Chem. 278, 14806-14811.
Go to original source...
Go to PubMed...
- Giunta, S., Belotserkovskaya, R., Jackson, S.P., 2010. DNA damage signaling in response to double-strand breaks during mitosis. J. Cell Biol. 190, 197-207.
Go to original source...
- Gorbunova, V., Seluanov, A., Pereira-Smith, O.M., 2002. Expression of human telomerase (hTERT) does not prevent stress-induced senescence in normal human fibroblasts but protects the cells from stress-induced apoptosis and necrosis. J. Biol. Chem. 277, 38540-38549.
Go to original source...
Go to PubMed...
- Hirao, A., Kong, Y.Y., Matsuoka, S., Wakeham, A., Ruland, J., Yoshida, H., et al., 2000. DNA damage-induced activation of p53 by the checkpoint kinase Chk2. Science 287, 1824-1827.
Go to original source...
Go to PubMed...
- Hurley, P.J., Wilsker, D., Bunz, F., 2007. Human cancer cells require ATR for cell cycle progression following exposure to ionizing radiation. Oncogene 26, 2535-2542.
Go to original source...
Go to PubMed...
- Jazayeri, A., Falck, J., Lukas, C., Bartek, J., Smith, G.C.M., Lukas, J., Jackson, S.P., 2006. ATM- and cell cycle-dependent regulation of ATR in response to DNA double-strand breaks. Nat. Cell Biol. 8, 37-45.
Go to original source...
Go to PubMed...
- Ke, N., Wang, X., Xu, X., Abassi, Y.A., 2011. The xCELLigence system for real-time and label-free monitoring of cell viability. Methods Mol. Biol. 740, 33-43.
Go to original source...
Go to PubMed...
- Kmochova, A., Tichy, A., Zarybnicka, L., Sinkorova, Z., Vavrova, J., Rehacek, V., et al., 2016. Modulation of ionizing radiation-induced effects by NU7441, KU55933 and VE821 in peripheral blood lymphocytes. J Appl. Biomed. 14, 19-24.
Go to original source...
- Lane, D.P., 1992. Cancer. p53 guardian of the genome. Nature 358, 15-16.
Go to original source...
Go to PubMed...
- Liu, S., Opiyo, S.O., Manthey, K., Glanzer, J.G., Ashley, A.K., Amerin, C., et al., 2012. Distinct roles for DNA-PK: ATM and ATR in RPA phosphorylation and checkpoint activation in response to replication stress. Nucleic Acids Res. 40, 10780-10794.
Go to original source...
Go to PubMed...
- Nikitaki, Z., Michalopoulos, I., Georgakilas, A.G., 2015. Molecular inhibitors of DNA repair: searching for the ultimate tumor killing weapon. Future Med Chem. 7, 1543-1558.
Go to original source...
Go to PubMed...
- Parsels, L.A., Qian, Y., Tanska, D.M., Gross, M., Zhao, L., Hassan, M.C., et al., 2011. Assessment of Chk1 phosphorylation as a pharmacodynamic biomarker of Chk1 inhibition. Clin. Cancer Res. 17, 3706-3715.
Go to original source...
Go to PubMed...
- Peddi, P., Loftin, C.W., Dickey, J.S., Hair, J.M., Burns, K.J., Aziz, K., et al., 2010. DNA-PKcs deficiency leads to persistence of oxidatively induced clustered DNA lesions in human tumor cells. Free Radic. Biol. Med. 48, 1435-1443.
Go to original source...
Go to PubMed...
- Pires, I.M., Olcina, M.M., Anbalagan, S., Pollard, J.R., Reaper, P.M., Charlton, P.A., et al., 2012. Targeting radiation-resistant hypoxic tumour cells through ATR inhibition. Br. J. Cancer 107, 291-299.
Go to original source...
Go to PubMed...
- Reaper, P.M., Griffiths, M.R., Long, J.M., Charrier, J.-D., Maccormick, S., Charlton, P.A., et al., 2011. Selective killing of ATM- or p53-deficient cancer cells through inhibition of ATR. Nat. Chem. Biol. 7, 428-430.
Go to original source...
Go to PubMed...
- Schiller, J.H., Harrington, D., Belani, C.P., Langer, C., Sandler, A., Krook, J., et al., 2002. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. New Engl. J. Med. 346, 92-98.
Go to original source...
Go to PubMed...
- Taylor, W.R., Stark, G.R., 2001. Regulation of the G2/M transition by p53. Oncogene 20, 1803-1815.
Go to original source...
Go to PubMed...
- Tibbetts, R.S., Brumbaugh, K.M., Williams, J.M., Sarkaria, J.N., Cliby, W.A., Shieh, S.-Y., et al., 1999. A role for ATR in the DNA damage-induced phosphorylation of p53. Genes Dev. 13, 152-157.
Go to original source...
Go to PubMed...
- Tichy, A., Durisova, K., Salovska, B., Pejchal, J., Zarybnicka, L., Vavrova, J., et al., 2014. Radio-sensitization of human leukaemic MOLT-4 cells by DNA-dependent protein kinase inhibitor, NU7441. Radiat. Environ. Biophys. 53, 83-92.
Go to original source...
Go to PubMed...
- Toledo, L.I., Altmeyer, M., Rask, M.-B., Lukas, C., Larsen, D.H., Povlsen, L.K., et al., 2013. ATR prohibits replication catastrophe by preventing global exhaustion of RPA. Cell 155, 1088-1103.
Go to original source...
Go to PubMed...
- Vávrová, J., Zárybnická, L., Lukášová, E., Řezáčová, M., Novotná, E., Sinkorová, Z., et al., 2013. Inhibition of ATR kinase with the selective inhibitor VE-821 results in radiosensitization of cells of promyelocytic leukaemia (HL-60). Radiat. Environ. Biophys. 52, 471-479.
Go to original source...
Go to PubMed...
- Wang, X.Q., Redpath, J.L., Fan, S.T., Stanbridge, E.J., 2006. ATR dependent activation of Chk2. J. Cell. Physiol. 208, 613-619.
Go to original source...
Go to PubMed...
- Zhao, H., Watkins, J.L., Piwnica-Worms, H., 2002. Disruption of the checkpoint kinase 1/cell division cycle 25A pathway abrogates ionizing radiation-induced S and G2 checkpoints. PNAS 99, 14795-14800.
Go to original source...
Go to PubMed...
- Zhuang, L., Cao, Y., Xiong, H., Gao, Q., Cao, Z., Liu, F., et al., 2011. Suppression of DNA-PKcs and Ku80 individually and in combination: Different effects of radiobiology in HeLa cells. Int. J. Oncol. 39, 443-451.
Go to original source...
Go to PubMed...